Rite Aid (RAD) April Comps Rose 3%

Rite Aid (NYSE: RAD) announced sales results for April.

Monthly Sales

For the four weeks ended Apr. 25, 2015, same store sales increased 3.0 percent over the prior-year period. April front-end same store sales, which were negatively impacted by 0.9 percent due to a shift in the timing of Easter, decreased 0.5 percent. Pharmacy same store sales, which included an approximate 145 basis points negative impact from new generic introductions, increased 4.6 percent. Prescription count at comparable stores increased 1.8 percent over the prior-year period.

Total drugstore sales for the four-week period increased 2.4 percent to $2.042 billion compared to $1.995 billion for the same period last year. Prescription sales accounted for 68.9 percent of drugstore sales, and third party prescription sales represented 97.7 percent of pharmacy sales.

Year-to-Date

Same store sales for the 8-week period ended Apr. 25, 2015 increased 3.6 percent over the prior-year period. Front-end same store sales increased 1.0 percent while pharmacy same store sales increased 4.9 percent. Prescription count at comparable stores increased 2.2 percent over the prior-year period.

Total drugstore sales for the 8 weeks ended Apr. 25, 2015 increased 3.2 percent with sales of $4.068 billion compared to $3.941 billion for the same period last year. Prescription sales represented 69.4 percent of total drugstore sales, and third party prescription sales represented 97.7 percent of pharmacy sales.

You May Also Be Interested In

• USA Rare Earth names Thras Moraitis as CEO, effective October 1
• BioLineRx and Hemispherian to present GLIX1 ovarian cancer data at ESMO
• Kamada signs $50M plasma supply deal, sales to begin in Q4 2026